Isis Pharmaceuticals

Listing Websites about Isis Pharmaceuticals

Filter Type:

Isis Pharmaceuticals Changes Name to Ionis Pharmaceuticals

(7 days ago) WebCARLSBAD, Calif., Dec. 18, 2015 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) today announced that the company has changed its name to Ionis …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Ionis Pharmaceuticals - Wikipedia

(1 days ago) Ionis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics. The company has 3 commercially approved medicines: Spinraza (Nusinersen), Tegsedi (Inotersen), and Waylivra (Volanesorsen) and has 4 drugs in pivotal studies: tominersen for Huntington’s disease, tofersen for SOD1-ALS, …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Every Moment Matters Ionis

(8 days ago) WebAs the leader in RNA-targeted therapeutics for more than three decades, Ionis has focused every moment on advancing drug discovery, development, and providing hope for patients. Our broadly …

Url: Visit Now

Category:  Drug Detail Drugs


Isis, biotech stocks move up - MarketWatch

(1 days ago) Web1.02%. NEW YORK (CBS.MW) -- Biotechnology stocks resumed their recent upswing Wednesday, with shares of Isis Pharmaceuticals among the leading advancers after …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Isis Pharmaceuticals Changes Name to Ionis Pharmaceuticals - PR …

(4 days ago) WebCARLSBAD, Calif., Dec. 18, 2015 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) today announced that the company has changed its name to Ionis …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Isis Pharma, biotech stocks move up - MarketWatch

(7 days ago) WebIsis Pharmaceuticals' stock continued to gain ground on Friday in the wake of the Lilly partnership. Shares rose $1.32, or 9 percent, to $16.35. Isis shares soared …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Isis Pharmaceuticals to change its name Ionis Pharmaceuticals

(8 days ago) WebIsis Pharmaceuticals on Friday announced that it will change its name to Ionis Pharmaceuticals.. The company's shares, which now trade on the Nasdaq under …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Home - Isispharma

(Just Now) WebMade in France. Isispharma is a French laboratory that formulates dermatological skincare products that are accessible and provide real results to preserve and restore your skin’s natural balance.

Url: Visit Now

Category:  Drug Detail Drugs


About Ionis Pharmaceuticals, Inc.

(4 days ago) WebMs. Cadoret-Manier is executive vice president, chief global product strategy and operations officer at Ionis Pharmaceuticals. She is a member of Ionis’ executive leadership team, …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Isis Stock Hits New 52-Week High (ISIS) - TheStreet

(Just Now) WebIsis has a market cap of $1.95 billion and is part of the health care sector and drugs industry. Shares are up 83.7% year to date as of the close of trading on Thursday. …

Url: Visit Now

Category:  Health Detail Drugs


ISIS Pharmaceuticals ISIS Stock Price, Company Overview & News …

(4 days ago) WebIsis Pharmaceuticals, Inc. engages in the development and commercialization of drugs to treat various health conditions, including inflammatory, viral, metabolic and …

Url: Visit Now

Category:  Pharmaceutical,  Health Detail Drugs


ISIS PHARMACEUTICALS, INC. : Stock Price US4643301090

(3 days ago) WebISIS PHARMACEUTICALS, INC. Ionis Pharmaceuticals, Inc. is engaged in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The Company …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Isis Pharma changes its name to not be confused with terror group

(6 days ago) WebIsis Pharma is going a step further than diet candy Ayds, which was forced to rebrand itself in the 1980s when the AIDS epidemic was raging. But the candy name …

Url: Visit Now

Category:  Drug Detail Drugs


Biogen Idec and Isis Pharmaceuticals Announce Strategic …

(2 days ago) WebAbout Isis Pharmaceuticals, Inc. Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Stock quote Ionis Pharmaceuticals, Inc.

(6 days ago) WebThe Investor Relations website contains information about Ionis Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


ISIS-3521. Isis Pharmaceuticals - PubMed

(1 days ago) WebISIS-3521 is a 20-mer antisense phosphorothioate oligonucleotide PKCa expression inhibitor, under development by Isis (formerly in collaboration with Novartis) for the …

Url: Visit Now

Category:  Drug Detail Drugs